An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: The IMPROVE study

Pharmacotherapy

Volumn 20, Issue 10 I, 2000, Pages 1149-1158

  Malone, D C ^a   Carter, B L ^a   Billups, S J ^a   Valuck, R J ^a   Barnette, D J ^a   Sintek, C D ^a   Okano, G J ^a   Ellis, S ^a   Covey, D ^a   Mason, B ^a   Jue, S ^a   Carmichael, J ^a   Guthrie, K ^a   Sloboda, L ^a   Dombrowski, R ^a   Geraets, D R ^a   Amato, M G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PHARMACY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PATIENT SATISFACTION; PHARMACEUTICAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS; SOLDIER;

EID: 0033779206     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.15.1149.34590     Document Type: Article

References (29)

1. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit
2. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team
3. Drug-related hospital admissions
4. Noncompliance with medication regimens and subsequent hospitalizations: Literature analysis and cost of hospitalization estimate
5. Drug-related morbidity and mortality: A cost-of-illness model
6. Opportunities and responsibilities in pharmaceutical care
7. Critical analysis of the pharmaceutical care research literature
8. The IMPROVE study: Background and study design
9. Characteristics of ambulatory care clinics and pharmacists in Veterans Affairs medical centers
10. Assessing the structure and process for delivering pharmaceutical care in Veterans Affairs medical centers: The IMPROVE study
11. The MOS short-form general health survey: Reliability and validity in a patient population
12. Indicators for the selection of ambulatory patients who warrant pharmacist monitoring
13. Estimating risk factors for patients with potential drug-related problems using electronic pharmacy data
14. Development of a chronic disease indicator score using a Veterans Affair medical center medication database
15. A general method of compliance assessment using centralized pharmacy records. Description and validation
16. Defining and measuring patient satisfaction with medical care
17. Use of the decision support system for VA cost-effectiveness research
18. Longitudinal data analysis for discrete and continuous outcomes
19. Ambulatory care clinical pharmacist interventions: The IMPROVE study
20. Can clinical pharmacists affect SF-36 scores in veterans?
21. Cost-justification of a clinical pharmacist-managed anticoagulation clinic
22. Comparison of an anticoagulation clinic with usual medical care
23. A randomized, controlled trial of clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy
24. Does increased access to primary care reduce hospital readmissions?
25. Clinical and economic impact of ambulatory care clinical pharmacists in the management of dyslipidemia in older patients
26. Where do elderly Veterans obtain care for acute myocardial infarction: Department of Veteran Affairs or Medicare?
27. Pharmaceutical services in the Department of Veterans Affairs